No headlines found.
Business Wire (Thu, 22-Feb 6:30 AM ET)
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates KRTX, SNCE, KAMN, BATL
Globe Newswire (Thu, 15-Feb 11:33 AM ET)
Kuehn Law Encourages KAMN, SNCE, KRTX, and BATL Investors to Contact Law Firm
Globe Newswire (Thu, 15-Feb 11:11 AM ET)
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates GMGI, KRTX, SIX, AVRO
PRNewswire (Thu, 15-Feb 11:00 AM ET)
Business Wire (Wed, 14-Feb 4:10 PM ET)
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates KRTX, DSKE, X, RYZB
Globe Newswire (Sat, 10-Feb 10:58 AM ET)
INVESTIGATION ALERT: Halper Sadeh LLC Investigates EVBG, CTLT, KRTX
Globe Newswire (Mon, 5-Feb 2:19 PM ET)
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates CVLY, PGTI, KRTX
PRNewswire (Mon, 29-Jan 11:26 PM ET)
Kuehn Law Encourages SNCE, MGRC, VINE, and KRTX Investors to Contact Law Firm
Globe Newswire (Mon, 29-Jan 12:22 PM ET)
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates KRTX, DSKE, CONN
Globe Newswire (Sat, 27-Jan 12:15 PM ET)
Karuna Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by unmet medical needs. Its product candidate, KarXT is an oral modulator of muscarinic receptors that are located both in the central nervous system, or CNS, and various peripheral tissues.
Karuna Therapeutics trades on the NASDAQ stock market under the symbol KRTX.
As of March 28, 2024, KRTX stock price was flat at $329.83 with million shares trading.
KRTX has a beta of 1.29, meaning it tends to be more sensitive to market movements. KRTX has a correlation of 0.10 to the broad based SPY ETF.
KRTX has a market cap of $12.60 billion. This is considered a Large Cap stock.
Last quarter Karuna Therapeutics reported $0 in Revenue and -$3.01 earnings per share. This fell short of revenue expectation by $-760,000 and missed earnings estimates by -$.36.
In the last 3 years, KRTX stock traded as high as $329.99 and as low as $92.26.
The top ETF exchange traded funds that KRTX belongs to (by Net Assets): VTI, VB, VBR, VXF, VHT.
KRTX has outperformed the market in the last year with a price return of +77.6% while the SPY ETF gained +33.6%. However, in the short term, KRTX had mixed performance relative to the market. It has underperformed in the last 3 months, returning +4.0% vs +10.1% return in SPY. But in the last 2 weeks, KRTX shares have fared better than the market returning +2.4% compared to SPY +1.7%.
KRTX support price is $327.62 and resistance is $332.04 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KRTX stock will trade within this expected range on the day.